Cannaisseur Group Inc. (TCRG): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$235.3K

As of 2025-12-31

-$362.7K

As of 2026-06-30

2022-12-31 Shareholders' Equity (USD) 2025-12-31

Period ended	Shareholders' Equity	Change YoY	Source filing
2025-12-31	-$235.3K	n/m	2026-03-23, Balance as of period end
2024-12-31	-$341.6K	n/m	2026-03-23, Balance as of period end
2023-12-31	-$130.9K	n/m	2025-03-21, Balance as of period end
2022-12-31	-$60.3K	n/a	2024-04-15, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Shareholders' Equity	Change YoY
Cannaisseur Group Inc. (TCRG)	2025-12-31	-$235.3K	n/m
Cyanotech Corp (CYAN)	2025-03-31	$8.88M	-24.8%
Natural Alternatives International Inc (NAII)	2026-06-30	$49.96M	-27.0%
C21 Investments Inc. (CWLXF)	2026-03-31	$25.43M	-11.3%
USANA Health Sciences Inc (USNA)	2026-01-03	$533.10M	+0.2%
Mannatech Inc (MTEX)	2025-12-31	-$5.22M	n/m
Nutra Pharma Corp (NPHC)	2025-12-31	-$16.83M	n/m
Charlie's Holdings, Inc. (CHUC)	2025-12-31	$3.42M	n/m
Adia Med, Inc. (ADIA)	2025-12-31	-$257.7K	n/m

Compare TCRG, CYAN, NAII, CWLXF side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗